Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Editas Medicine Inc (NASDAQ: EDIT) was $3.92 for the day, up 1.29% from the previous closing price of $3.87. In other words, the price has increased by $1.29 from its previous closing price. On the day, 1.04 million shares were traded. EDIT stock price reached its highest trading level at $3.99 during the session, while it also had its lowest trading level at $3.85.
Ratios:
Our analysis of EDIT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.85. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2024, Upgraded its rating to Buy and sets its target price to $15 from $13 previously.
On May 09, 2024, Morgan Stanley Upgraded its rating to Equal-Weight which previously was Underweight but kept the price unchanged to $7.
Citigroup Upgraded its Neutral to Buy on October 24, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 25 ’24 when Burkly Linda sold 11,886 shares for $5.42 per share. The transaction valued at 64,370 led to the insider holds 73,136 shares of the business.
Mei Baisong sold 6,619 shares of EDIT for $34,456 on Jul 19 ’24. The EVP, CHIEF MEDICAL OFFICER now owns 134,413 shares after completing the transaction at $5.21 per share. On Jun 04 ’24, another insider, O’Neill Gilmore Neil, who serves as the CEO of the company, sold 12,191 shares for $5.50 each. As a result, the insider received 66,997 and left with 315,279 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 323307488 and an Enterprise Value of 82893632. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.82 while its Price-to-Book (P/B) ratio in mrq is 1.39. Its current Enterprise Value per Revenue stands at 1.237 whereas that against EBITDA is -0.4.
Stock Price History:
Over the past 52 weeks, EDIT has reached a high of $11.69, while it has fallen to a 52-week low of $3.71. The 50-Day Moving Average of the stock is -18.94%, while the 200-Day Moving Average is calculated to be -44.85%.
Shares Statistics:
EDIT traded an average of 1.98M shares per day over the past three months and 1464540 shares per day over the past ten days. A total of 81.77M shares are outstanding, with a floating share count of 81.70M. Insiders hold about 0.94% of the company’s shares, while institutions hold 69.50% stake in the company. Shares short for EDIT as of 1722384000 were 16133636 with a Short Ratio of 8.15, compared to 1719532800 on 16743787. Therefore, it implies a Short% of Shares Outstanding of 16133636 and a Short% of Float of 24.8.
